Coding Tip: New Technology ICD-10-PCS Section “X” DRUGS

by Jan 23, 2017Industry News, Medical Coding Tips0 comments

Kim Carrier RHIT, CDIP, CCS, CCS-P
Director of Coding Quality Assurance
AHIMA Approved ICD-10-CM/PCS Trainer

Section “X” is a separate place within ICD-10-PCS for certain new technology procedures (like new technology drugs).  Section “X” does not introduce any new coding concepts or unusual guidelines for correct coding and maintains continuity with the other sections in ICD-10-PCS. The same root operation and body part values are used in section “X” as in other sections.  The seventh character in section “X” is used to indicate the new technology group.  This is a number or letter that changes each year that new technology codes are added.  It is only used to indicate the year the code was created and all codes for that update year will have the same qualifier.

Section “X” codes are standalone codes. No additional codes from other sections in ICD-10-PCS are necessary for reporting as the specific procedure is described in the code title from section “X”.

New Technology section codes are easily found by looking in the ICD-10-PCS Index or the Tables. The name of the new technology device, substance or technology for a section “X” code is included as a main term.  They are also listed under the main term “New Technology”.

New Technology Drugs for 2017

Andexanet Alfa (factor Xa inhibitor reversal agent) rivaroxaban/Xarelto®, apixaban/Eliquis®, and edoxaban/Savaysa® belong to the factor Xa inhibitor class—also referred to as NOACs or non-vitamin K antagonist oral anticoagulants.

Blinatumomab (antineoplastic immunotherapy)

Ceftazidime-Avibactam (anti-infective)

Defibrotide Sodium (anticoagulant)

Idarucizumab (dabigatran/Pradaxa® reversal agent)

Isavuconazole (anti-infective)

Uridine Triacetate/VISTOGARD (indicated for emergency treatment f 5-FU or capecitabine overexposure)

Happy Coding!

The information contained in this coding advice is valid at the time of posting. Viewers are encouraged to research subsequent official guidance in the areas associated with the topic as they can change rapidly.

Pin It on Pinterest

Share This